U.S. Markets closed

Lipidor AB (publ) (LIPI.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
Add to watchlist
15.02-0.20 (-1.31%)
At close: 5:24PM CEST

Lipidor AB (publ)

MMK, Stockholm University
Svante Arrhenius väg 16 C
Stockholm 106 91
Sweden

http://lipidor.se

Sector(s)Healthcare
IndustryDrug Manufacturers—General
Full Time Employees1

Key Executives

NameTitlePayExercisedYear Born
Mr. Ola HolmlundChief Exec. Officer439kN/A1969
Mr. Olle HolmertzFounder & Bus. Controller540kN/A1963
Mr. Anders Carlsson Ph.D.Co-Founder, Sr. Advisor & Chief Devel. OfficerN/AN/AN/A
Dr. Bengt HerslöfCo-founder & Sr. Scientific AdvisorN/AN/AN/A
Dr. Jan Holmbäck Ph.D.Co-Founder & Chief Scientific OfficerN/AN/A1957
Dr. Gerhard MikscheCo-FounderN/AN/AN/A
Mr. Michael Owens B.A., B.S., B.S.B.AChief Financial OfficerN/AN/A1956
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, and AKP-03 AKP-07 for eczema. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. The company has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. Lipidor AB (publ) was founded in 2009 and is based in Stockholm, Sweden.

Corporate Governance

Lipidor AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.